Navigation Links
New Revolutionary Drug Could Stop the Spread of HIV

A new revolutionary drug manufactured by a US biotechnology company could block the spread of HIV, say scientists after finding its benefits in a small-scale human trial. //

Human Immunodeficiency Virus (HIV) steadily weakens the body's immune system until it can no longer fight off infections such as pneumonia, diarrhea, tumours and other illnesses.

Unable to fight back, most people die within three years of the first signs of the disease. Most of all HIV infections have been transmitted through unprotected sexual intercourse with someone who is already infected with the disease.

Panacos Pharmaceuticals in Gaithersburg, Maryland, which is developing PA-457, hopes now to begin trials this month to test how well the drug works in patients whose existing drug regimes are failing, reported the science portal EurekAlert.

About 80 percent of people being treated for HIV show resistance to one or more of their drugs, a spokesman for Panacos said. There are several existing ways of tackling HIV.

Many medications work by blocking reverse transcriptase, an enzyme that enables HIV to replicate within a cell. Others disable protease, which helps to assemble the virus into particles to infect other cells.

The new drug, a derivative of betulinic acid, is a cheap by-product of the paper industry and one of a new class of drugs called maturation inhibitors.

It works by interfering with the production of the capsid protein, a conical "shield" which protects the genetic material of HIV inside it.

The drug is still in its early stages, and will not be generally available for at least three years, he said.

The small human trial of the drug reported that, given on its own, it rapidly clears most HIV from the blood, the study published in the Journal of Virology claimed.

Worldwide, over 36 million people were infected at the end of 2000 with HIV, the most dangerous
'"/>




Page: 1 2

Related medicine news :

1. Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
2. Revolutionary Pill Cuts Risk of Breast Cancer
3. A Revolutionary New Treatment For Cancer Available In Australia
4. Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms
5. Revolutionary Net To Control Malaria
6. Revolutionary Net To Control Malaria
7. Revolutionary Eye Cancer Treatment
8. Revolutionary Pill Promises Relief for Hay Fever Sufferers
9. Lean Protein Could Be Key to Obesity Drugs
10. Nasal Spray Could Take Drugs Direct to Brain.
11. Nasal Spray Could Take Drugs Directly to Brain
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Revolutionary Drug Could Stop the Spread HIV

(Date:7/1/2015)... GEORGIA (PRWEB) , ... July 01, 2015 , ... ... Institute for Biomedical Sciences at Georgia State University and a Georgia Research Alliance ... grant to develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant from ...
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 , ... ... which DNA is wound, histones, remain constant in the brain, never changing after development ... have discovered that histones are steadily replaced in brain cells throughout life – a ...
(Date:7/1/2015)... ... July 01, 2015 , ... SuiteRx, innovative leaders in pharmacy ... pharmacy operations, announces the most recent positioning of SuiteRx CEO, Nicholas Zener Pharm. ... at the Venetian Las Vegas, Nevada. During this event, SuiteRx will be ...
(Date:7/1/2015)... ... July 01, 2015 , ... DIC ... plant for Linablue®, Spirulina-derived natural blue food coloring. Construction of the plant, which ... U.S. Spirulina* production base, began in May 2014. After commissioning, commercial production is ...
(Date:7/1/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. ... Set for March 6th - 8th, the 2016 meeting will be held at the ... fundamentals of nasal surgery through the most modern advancements and updates in rhinoplasty and ...
Breaking Medicine News(10 mins):Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3
... , , LOS ANGELES, Sept. ... manufacturer of BPA-free baby bottles that provide a safe alternative ... currently banned in Canada, Minnesota, Connecticut and under scrutiny in ... Assembly members to support the Toxics-Free Babies and Toddlers ...
... of voting Iowans believe the government should be given additional ... them sick, according to a new poll commissioned by The ... Opinion Strategies. Support for stronger food protections is ... The statewide survey of 511 registered voters, conducted between August ...
... MOUNT LAUREL, N.J., Sept. 2 MedQuist Inc. (Nasdaq: ... a five-year $25 million revolving credit facility. The credit ... an option whereby the Company may increase its maximum credit ... The credit facility is a working capital facility that ...
... , , MONTREAL, ... in R&D, in partnership with industry leading manufacturers (Sirona, ... Systems today announced the launch of ProDrive products nationwide ... Dental Canada. Canada,s largest dental products reseller, Patterson has ...
... , , WASHINGTON, Sept. 2 ... to President Obama inviting him to address a Joint Session of Congress on Wednesday, ... text of the letter to the President: , , September ... , Washington, D.C. 20500 , , Dear Mr. President: , ...
... Md., Sept. 2 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex") (Nasdaq: ... services in the People,s Republic of China, today,announced its participation in ... Healthcare Corporate Day, to be held September 11, 2009, ... institutional investors, throughout the day., ...
Cached Medicine News:Health News:BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for California's Toxics-Free Babies and Toddlers Act (SB 797) 2Health News:BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for California's Toxics-Free Babies and Toddlers Act (SB 797) 3Health News:BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for California's Toxics-Free Babies and Toddlers Act (SB 797) 4Health News:Pew poll: 9 in 10 Iowa voters support more government oversight of food 2Health News:MedQuist Announces Establishment of Revolving Credit Facility and Payment of Special Cash Dividend 2Health News:ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 2Health News:Chindex International Announces September Investor Conferences Participation 2
(Date:7/1/2015)... 2015 Research and ... the "Future Horizons and Growth Strategies in ... and Country Forecasts" report to their offering. ... the European Blood Banking Market 2015 is a ... current suppliers and potential market entrants identify and ...
(Date:7/1/2015)... July 1, 2015  Celsion Corporation (NASDAQ: CLSN ... Michael H. Tardugno , Chairman, President and CEO, ... Healthcare Conference on Wednesday, July 8, 2015, at 4:15 ... Parker Meridien Hotel located at 119 W. 56th Street, ... A copy of the presentation will be available ...
(Date:7/1/2015)... (Continental) announced it is expanding its Baltimore -based clinical studies network and ... for unique patient populations.  Photo - ... ... ... "Continental hosts clinical studies for physicians ...
Breaking Medicine Technology:European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
Hook design lifts and separates tissue for efficient dissection. Cautery action facilitates immediate control of bleeders....
This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....
Medicine Products: